Related Experiment Video
Updated: May 16, 2026
10:03
Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
Accumulation of α-synuclein triggered by presynaptic dysfunction.
Yasuto Nakata1, Toru Yasuda, Masahiro Fukaya
1Department of Neurology, Division of Neuroregenerative Medicine, Kitasato University School of Medicine, Sagamihara, Kanagawa 252-0374, Japan.
Summary
SNARE complex dysfunction, not alpha-synuclein (αSyn) itself, may initiate Lewy body diseases. This study in Snap25 mutant mice shows SNARE dysfunction triggers αSyn mislocalization and accumulation, suggesting a key role in α-synucleinopathies.
Area of Science:
- Neuroscience
- Molecular Biology
- Pathology
Background:
- Abnormal alpha-synuclein (αSyn) aggregates are hallmarks of dementia with Lewy bodies and Parkinson's disease.
- αSyn interacts with the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex, crucial for neurotransmission.
- Previous studies noted altered SNARE protein distribution in αSyn-related neurodegenerative diseases.
Purpose of the Study:
- To investigate the impact of SNARE complex dysfunction on endogenous αSyn.
- To explore the role of synaptosomal-associated protein of 25 kDa (SNAP-25) phosphorylation in αSyn pathology.
- To determine if SNARE dysfunction is an initiating factor in α-synucleinopathies.
Main Methods:
- Utilized Snap25(S187A/S187A) mutant mice with unphosphorylatable SNAP-25.
- Performed age-dependent analysis of αSyn and phosphorylated αSyn distribution.
- Employed electron microscopy to examine synaptic vesicle morphology and protein localization in glutamatergic nerve terminals.
Main Results:
- Snap25(S187A/S187A) mice exhibited age-dependent αSyn mislocalization and accumulation in hypertrophied glutamatergic terminals.
- Electron microscopy revealed condensed synaptic vesicles and αSyn in the periactive zone.
- No abnormalities were observed in the nigrostriatal dopaminergic system of these mutant mice.
Conclusions:
- SNARE complex dysfunction, specifically altered SNAP-25, appears to be an initial trigger for αSyn mislocalization and aggregation.
- This dysfunction may represent a critical pathomechanism in the development of α-synucleinopathies.
- Findings implicate SNARE complex integrity as a potential therapeutic target.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...